• Home
  • Contatti
  • Informativa & Cookie
  • EnglishEnglish
    • ItalianoItaliano
    • DeutschDeutsch
    • EnglishEnglish
    • EspañolEspañol
    • FrançaisFrançais
    • PortuguêsPortuguês
    • NederlandsNederlands

KM 0

Tutto a km 0

  • Biological agriculture
  • Ecology
  • Ecotourism
  • Environment
  • Farmhouse
  • Green
  • Km 0
  • Miscellany

Month: May 2018

TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten® for the Treatment of Intradialytic Hypotension

3 years ago by AdminGreen

Phase II clinical trials in patients undergoing hemodialysis to be initiated in Q4, 2018 TrioxBio Inc., a clinical-stage biopharmaceutical company specializing in the development of drugs to treat diseases and medical conditions related to the pathological overproduction of nitric oxide (NO), today announced that the U.S.… Read More

  • Popular
  • Latest
  • Tags
  • 2018 Budget – Sagentia Response: Reducing Plastic Needs a Focus on Science and Innovation

    October 31, 2018
  • CE Mark and Health Canada Regulatory Approvals for Datum Dental’s OSSIX Bone

    June 18, 2018
  • Chair of Better Globe Group Named Business Worldwide Magazine’s Man of the Year 2018

    Chair of Better Globe Group Named Business Worldwide Magazine’s Man of the Year 2018

    January 25, 2019
  • Michelin-Level Italian Dining in Copenhagen

    May 1, 2019
  • Oman Aviation Group Brings the Sultanate to the Forefront as a Leading Tourism and Investment Hub

    Oman Aviation Group Brings the Sultanate to the Forefront as a Leading Tourism and Investment Hub

    April 29, 2019
  • Emakina Group Results 2018: Income of EUR 92,389,601, Up 15.0%; EBITDA of EUR 6,107,455, Up 6.6%

    March 29, 2019
  • Contatti
  • Informativa & Cookie
Back To Top

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi